Skip to content

Clinical trials

Completed Hepatitis C trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C Status: Completed Clear all

1,217 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20009
200114
200224
200320
200426
200551
200637
200753
200853
200973
201071
201191
201278
201383
201494
201595
201677
201771
201848
201948
202022
202120
202216
202312
20244

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed1,217

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences102
Merck Sharp & Dohme LLC77
AbbVie71
Bristol-Myers Squibb67
National Institute of Allergy and Infectious Diseases (NIAID)28
Tibotec Pharmaceuticals, Ireland28
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)19
AbbVie (prior sponsor, Abbott)17
Vertex Pharmaceuticals Incorporated15
ANRS, Emerging Infectious Diseases14

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C1,217
Hepatitis C, Chronic248
HIV Infections86
Fibrosis64
Acquired Immunodeficiency Syndrome61
Hepatitis55
Hepatitis B53
Liver Diseases47
Liver Cirrhosis31
Carcinoma, Hepatocellular26

Trials

Showing 76 to 100 of 1,217. Each trial links to its page on Pharma Observatory.

1,117 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.